Literature DB >> 7810074

Molecular mechanisms of androgen action.

J Lindzey1, M V Kumar, M Grossman, C Young, D J Tindall.   

Abstract

Androgens directly regulate a vast number of physiological events. These direct androgen effects are mediated by a nuclear receptor that exhibits four major functions or activities: steroid binding, DNA binding, transactivation, and nuclear localization. The SBD consists of a hydrophobic pocket of amino acids that exhibits high-affinity, androgen-specific binding. Based on studies of mutant AR, it appears that a number of different amino acids contribute to the steroid binding characteristics of the AR. The DNA binding domain confers sequence-specific binding to structures called androgen-responsive elements. The specificity of steroid binding and DNA binding provides a crucial basis for androgen-specific regulation of target genes. The nuclear localization signal shares homology with known nuclear localization signals and, coupled with the presence of androgens, is responsible for localizing the AR to the nucleus. The transactivation functions reside mostly in the NH2 terminus but the responsible domains are as yet poorly defined. Though the different domains can act as independent moieties, one domain can clearly alter the behavior of another domain. For instance, the SBD appears to inhibit the transactivating functions until steroid is bound and the amino terminus prevents DNA binding activity until steroid is bound. The relative ease of introducing mutations with polymerase chain reaction technology will facilitate further delineation of critical amino acids and domains responsible for the various activities of the AR. The recent cloning and characterization of AR promoters revealed that the AR genes are driven by a TATA-less promoter characteristics of housekeeping genes. Analysis of transcription rates, mRNA levels, and protein levels indicates that androgens and pkA and pkC pathways modulate expression of AR mRNA and protein. This indicates that the same signal pathways that interact to regulate androgen target genes also regulate the levels of AR in the target tissues. Surprisingly few androgen-regulated genes have been well characterized for the mechanisms by which androgen regulates the gene. The C(3), Slp, probasin, PSA, and hKLK2 genes have provided examples where androgens regulate transcription. Posttranscriptional regulation by androgens has been demonstrated for the SVP1, 2, 3, and 4 and AR genes. The mechanisms underlying posttranscriptional regulation are poorly defined but substantial progress has been made in defining the critical elements that mediate transcriptional effects of androgens. Transcriptional effects are mediated through binding of androgen-AR complexes to specific DNA sequences called AREs. Simple AREs such as those found in C(3) and kallikrein genes tend to be permissive in that GR and PR can also act through the same element.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7810074     DOI: 10.1016/s0083-6729(08)61151-6

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  14 in total

1.  Identification of two novel cis-elements in the promoter of the prostate-specific antigen gene that are required to enhance androgen receptor-mediated transactivation.

Authors:  J Zhang; S Zhang; P E Murtha; W Zhu; S S Hou; C Y Young
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

2.  Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-κB, and androgen receptor signaling.

Authors:  Gagan Deep; Subhash C Gangar; Nicholas H Oberlies; David J Kroll; Rajesh Agarwal
Journal:  Mol Carcinog       Date:  2010-10       Impact factor: 4.784

Review 3.  Hormonal control of Sertoli cell metabolism regulates spermatogenesis.

Authors:  Marco G Alves; Luís Rato; Rui A Carvalho; Paula I Moreira; Sílvia Socorro; Pedro F Oliveira
Journal:  Cell Mol Life Sci       Date:  2012-07-20       Impact factor: 9.261

4.  From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells.

Authors:  H Y Kang; H K Lin; Y C Hu; S Yeh; K E Huang; C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

5.  Protein B23/nucleophosmin/numatrin nuclear dynamics in relation to protein kinase CK2 and apoptotic activity in prostate cells.

Authors:  Guixia Wang; Yunqian Pan; Kashif A Ahmad; Khalil Ahmed
Journal:  Biochemistry       Date:  2010-05-11       Impact factor: 3.162

6.  Hormonal and cellular regulation of Sertoli cell anti-Müllerian hormone production in the postnatal mouse.

Authors:  L Al-Attar; K Noël; M Dutertre; C Belville; M G Forest; P S Burgoyne; N Josso; R Rey
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

7.  Heterogeneous nuclear ribonucleoprotein A/B and G inhibits the transcription of gonadotropin-releasing-hormone 1.

Authors:  Sheng Zhao; Wayne J Korzan; Chun-Chun Chen; Russell D Fernald
Journal:  Mol Cell Neurosci       Date:  2007-08-29       Impact factor: 4.314

8.  Inhibition of Androgen Receptor Function and Level in Castration-Resistant Prostate Cancer Cells by 2-[(isoxazol-4-ylmethyl)thio]-1-(4-phenylpiperazin-1-yl)ethanone.

Authors:  Khalid Z Masoodi; Kurtis Eisermann; Zhenyu Yang; Javid A Dar; Laura E Pascal; Minh Nguyen; Katherine O'Malley; Erica Parrinello; Firuz G Feturi; Alex N Kenefake; Joel B Nelson; Paul A Johnston; Peter Wipf; Zhou Wang
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

9.  Physical and functional interaction of androgen receptor with calmodulin in prostate cancer cells.

Authors:  Eugenia Cifuentes; Jennifer M Mataraza; Barbara A Yoshida; Mani Menon; David B Sacks; Evelyn R Barrack; G Prem-Veer Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-26       Impact factor: 11.205

Review 10.  Targeting molecular resistance in castration-resistant prostate cancer.

Authors:  Thenappan Chandrasekar; Joy C Yang; Allen C Gao; Christopher P Evans
Journal:  BMC Med       Date:  2015-09-01       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.